Brouhard B H, Cunningham R J, Petrusick T W, Berger M, Travis L B
J Urol. 1979 May;121(5):672-4. doi: 10.1016/s0022-5347(17)56934-7.
The plasma kallikrein-kinin system, a potent vasodilator, has been implicated in causing the protein loss of the idiopathic nephrotic syndrome. However, the kidney possesses a kallikrein-kinin system separate from the plasma system. Thus, urinary kallikrein may reflect more accurately intrarenal events. Using a radiochemical esterolytic assay we measured the urinary kallikrein excretion in a patient with a minimal lesion nephrotic syndrome during relapse. Protein excretion was initially elevated (8.1 plus or minus 2.0 gm. per 24 hours) as was urinary kallikrein excretion (96.4 plus or minus 46.6 EU per 24 hours). After initiation of steroid therapy protein and kallikrein excretion decreased significantly (p less than 0.05). During the entire study kallikrein excretion was significantly correlated with protein excretion (r equals 0.89, p less than 0.01). It is tempting to speculate that activation of the intrarenal kallikrein-kinin system participates in the protein loss characteristic of the nephrotic syndrome.
血浆激肽释放酶-激肽系统是一种强效血管舒张剂,被认为与特发性肾病综合征的蛋白质丢失有关。然而,肾脏拥有一个独立于血浆系统的激肽释放酶-激肽系统。因此,尿激肽释放酶可能更准确地反映肾内情况。我们使用放射化学酯酶测定法,对一名微小病变型肾病综合征复发患者的尿激肽释放酶排泄情况进行了测量。蛋白质排泄最初升高(每24小时8.1±2.0克),尿激肽释放酶排泄也升高(每24小时96.4±46.6酶单位)。开始使用类固醇治疗后,蛋白质和激肽释放酶排泄显著下降(p<0.05)。在整个研究过程中,激肽释放酶排泄与蛋白质排泄显著相关(r=0.89,p<0.01)。我们不禁推测,肾内激肽释放酶-激肽系统的激活参与了肾病综合征的蛋白质丢失特征。